Company Filing History:
Years Active: 2021-2022
Title: Michael Graham - Innovator in RNA Interference Therapies
Introduction
Michael Graham is a notable inventor based in San Mateo, California. He has made significant contributions to the field of biotechnology, particularly in the development of RNA interference (RNAi) therapies. With a total of two patents to his name, Graham is dedicated to advancing medical treatments for serious health conditions.
Latest Patents
Graham's latest patents include innovative reagents for the treatment of oculopharyngeal muscular dystrophy (OPMD). This patent focuses on RNAi reagents designed to treat individuals suffering from OPMD or those predisposed to the condition. Additionally, he has developed reagents for the treatment of hepatitis B virus (HBV) infection, which also utilizes RNAi technology to combat the virus in infected individuals.
Career Highlights
Michael Graham is currently associated with Benitec Biopharma Limited, a company known for its pioneering work in gene silencing and RNAi therapies. His role at the company allows him to contribute to groundbreaking research and development in the field of biotechnology.
Collaborations
Graham has collaborated with esteemed colleagues such as David A Suhy and Tin Mao. These partnerships enhance the innovative potential of his work and contribute to the advancement of RNAi therapies.
Conclusion
Michael Graham's work in RNA interference therapies represents a significant advancement in the treatment of serious diseases. His patents and collaborations reflect his commitment to improving healthcare through innovative solutions.